Replication-deficient RNA viruses as vaccines

Details for Australian Patent Application No. 2006212385 (hide)

Owner Max-Planck Gesellschaft zur Forderung der Wissenschaften e.v.

Inventors Bossow, Sascha; Neubert, Wolfgang J.; Schlecht, Sabine

Agent Davies Collison Cave

Pub. Number AU-B-2006212385

PCT Pub. Number WO2006/084746

Priority 10 2005 006 388.8 11.02.05 DE

Filing date 10 February 2006

Wipo publication date 17 August 2006

Acceptance publication date 15 December 2011

International Classifications

C07K 14/115 (2006.01) Peptides having more than 20 amino acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/084746 Priority application(s): WO2006/084746

15 December 2011 Application Accepted

  Published as AU-B-2006212385

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006212392-Method for isolating nucleic acids, the nucleic acids being immobilised on a matrix at an increased temperature

2006212322-Use of iron(III) complex compounds